Bertram Pitt

Bertram Pitt

UNVERIFIED PROFILE

Are you Bertram Pitt?   Register this Author

Register author
Bertram Pitt

Bertram Pitt

Publications by authors named "Bertram Pitt"

Are you Bertram Pitt?   Register this Author

100Publications

2148Reads

23Profile Views

Eplerenone prevents an increase in serum carboxy-terminal propeptide of procollagen type I after myocardial infarction complicated by left ventricular dysfunction and/or heart failure.

Eur J Heart Fail 2020 Apr 3. Epub 2020 Apr 3.

Université de Lorraine, INSERM, Centre d'Investigations Cliniques Plurithématique 1433, INSERM U1116, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ejhf.1812DOI Listing
April 2020

Prognostic impact of plasma volume estimated from hemoglobin and hematocrit in heart failure with preserved ejection fraction.

Clin Res Cardiol 2020 Apr 6. Epub 2020 Apr 6.

Centre d'Investigations Cliniques 1433, Université de Lorraine, INSERM, CHRU de Nancy, Inserm 1116 and INI-CRCT (Cardiovascular and Renal Clinical Trialists) F-CRIN Network, Institut Lorrain du cœur Et des, Vaisseaux Louis Mathieu, 4, rue du Morvan, 54500, Vandoeuvre-Les-Nancy, Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00392-020-01639-4DOI Listing
April 2020

Visit-to-visit blood pressure variation and outcomes in heart failure with reduced ejection fraction: findings from the Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms trial.

J Hypertens 2020 Mar;38(3):420-425

Université de Lorraine, INSERM, Centre d'Investigations Cliniques-Plurithématique 1433, and INSERM U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000002275DOI Listing
March 2020

Impact of pulmonary disease on the prognosis in heart failure with preserved ejection fraction: the TOPCAT trial.

Eur J Heart Fail 2020 Mar 31;22(3):557-559. Epub 2019 Oct 31.

Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ejhf.1593DOI Listing
March 2020

Mineralocorticoid Receptor Antagonists, Blood Pressure, and Outcomes in Heart Failure With Reduced Ejection Fraction.

JACC Heart Fail 2020 Mar 8;8(3):188-198. Epub 2020 Jan 8.

British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchf.2019.09.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086149PMC
March 2020

Interactions between left ventricular ejection fraction, sex and effect of neurohumoral modulators in heart failure.

Eur J Heart Fail 2020 Mar 2. Epub 2020 Mar 2.

BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ejhf.1776DOI Listing
March 2020

Determinants of anti-fibrotic response to mineralocorticoid receptor antagonist therapy: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) and Early Eplerenone Treatment in Patients with Acute ST-elevation Myocardial Infarction without Heart Failure (REMINDER) trials.

Clin Res Cardiol 2020 Feb 27;109(2):194-204. Epub 2019 Jun 27.

INSERM, Centre d'Investigations Cliniques Plurithématique 1433, INSERM U1116, Université de Lorraine, CHRU de Nancy, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Institut Lorrain du Cœur et des Vaisseaux Louis Mathieu, 4 Rue du Morvan, 54500, Vandoeuvre lès Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00392-019-01500-3DOI Listing
February 2020

Early Effects of Starting Doses of Enalapril in Patients with Chronic Heart Failure in the SOLVD Treatment Trial.

Am J Med 2020 Feb 8;133(2):e25-e31. Epub 2019 Aug 8.

Veterans Affairs Medical Center, Washington, DC; Georgetown University, Washington, DC; George Washington University, Washington, DC. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjmed.2019.06.053DOI Listing
February 2020

Sex differences in mineralocorticoid receptor antagonist trials: a pooled analysis of three large clinical trials.

Eur J Heart Fail 2020 Feb 19. Epub 2020 Feb 19.

Centre d'Investigation Clinique-Plurithématique INSERM CIC-P 1433, and INSERM U1116, CHRU Nancy Brabois, F-CRIN INI-CRCT, Université de Lorraine, Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ejhf.1740DOI Listing
February 2020

Medical Therapies for Heart Failure With Preserved Ejection Fraction.

Hypertension 2020 Jan 2;75(1):23-32. Epub 2019 Dec 2.

Universite de Lorraine, Inserm, Centre d'Investigations Cliniques-1433 and F-CRIN INI CRCT, Nancy, France (F.Z.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/HYPERTENSIONAHA.119.14057DOI Listing
January 2020

Income level and inequality as complement to geographical differences in cardiovascular trials.

Am Heart J 2019 12 1;218:66-74. Epub 2019 Sep 1.

Université de Lorraine, Inserm, Centre d'Investigation Clinique Plurithématique 1433, U1116, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ahj.2019.08.019DOI Listing
December 2019

MRAs in Elderly HF Patients: Individual Patient-Data Meta-Analysis of RALES, EMPAHSIS-HF, and TOPCAT.

JACC Heart Fail 2019 Dec;7(12):1012-1021

Université de Lorraine, Centre d'Investigation Clinique-Plurithématique INSERM 1433, and Cardiovascular and Renal Clinical Trialists, INSERM U1116, CHRU Nancy Brabois, Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchf.2019.08.017DOI Listing
December 2019

Mean BMI, visit-to-visit BMI variability and BMI changes during follow-up in patients with acute myocardial infarction with systolic dysfunction and/or heart failure: insights from the High-Risk Myocardial Infarction Initiative.

Clin Res Cardiol 2019 Nov 5;108(11):1215-1225. Epub 2019 Apr 5.

Université de Lorraine, INSERM, Centre d'Investigation Clinique et Plurithématique 1433, INSERM U1116, CHRU de Nancy, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00392-019-01453-7DOI Listing
November 2019

Eplerenone in patients with myocardial infarction and "mid-range" ejection fraction: An analysis from the EPHESUS trial.

Clin Cardiol 2019 Nov 3;42(11):1106-1112. Epub 2019 Sep 3.

Université de Lorraine, Centre d'Investigation Clinique- Plurithématique Inserm CIC-P 1433, Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/clc.23261DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837025PMC
November 2019

Digoxin Discontinuation and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.

J Am Coll Cardiol 2019 Aug;74(5):617-627

Veterans Affairs Medical Center, Washington, DC; Georgetown University, Washington, DC; George Washington University, Washington, DC. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2019.05.064DOI Listing
August 2019

Impact of eplerenone on major cardiovascular outcomes in patients with systolic heart failure according to baseline heart rate.

Clin Res Cardiol 2019 Jul 2;108(7):806-814. Epub 2019 Jan 2.

Department of Epidemiology and Preventive Medicine, CCRE Therapeutics, Monash University/Alfred Hospital, 553 St Kilda Rd, Melbourne, VIC, 3004, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00392-018-1410-4DOI Listing
July 2019

Editor's Choice- Impact of insulin-treated diabetes on cardiovascular outcomes following high-risk myocardial infarction.

Eur Heart J Acute Cardiovasc Care 2019 Apr 27;8(3):231-241. Epub 2018 Sep 27.

3 Université de Lorraine, Centre d'Investigations Cliniques Plurithématique, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2048872618803701DOI Listing
April 2019

Renal function stratified dose comparisons of eplerenone versus placebo in the EMPHASIS-HF trial.

Eur J Heart Fail 2019 03 15;21(3):345-351. Epub 2019 Feb 15.

National Institute of Health and Medical Research (INSERM), Center for Clinical Multidisciplinary Research 1433, INSERM U1116, University of Lorraine, Regional University Hospital of Nancy, French Clinical Research Infrastructure Network (F-CRIN) Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists (INI-CRCT), Nancy, France.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ejhf.1400
Publisher Site
http://dx.doi.org/10.1002/ejhf.1400DOI Listing
March 2019

The renin-angiotensin-aldosterone system and its suppression.

J Vet Intern Med 2019 Mar 26;33(2):363-382. Epub 2019 Feb 26.

Department of Medicine, University of Michigan School of Medicine, Ann Arbor, Michigan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jvim.15454DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430926PMC
March 2019

Beware of on-treatment safety analyses.

Clin Trials 2019 02 16;16(1):63-70. Epub 2018 Nov 16.

3 University of Michigan, Ann Arbor, MI, USA.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/1740774518812774
Publisher Site
http://dx.doi.org/10.1177/1740774518812774DOI Listing
February 2019

Potassium binders for the prevention of hyperkalaemia in heart failure patients: implementation issues and future developments.

Eur Heart J Suppl 2019 Feb 26;21(Suppl A):A55-A60. Epub 2019 Feb 26.

Division of Cardiology, Department of Medicine, University of Michigan School of Medicine, Ann Arbor, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/suy034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392413PMC
February 2019

Incidence, Predictors, and Outcome Associations of Dyskalemia in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.

JACC Heart Fail 2019 01 12;7(1):65-76. Epub 2018 Dec 12.

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchf.2018.10.003DOI Listing
January 2019

Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease.

JACC Heart Fail 2019 01;7(1):25-32

Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchf.2018.10.017DOI Listing
January 2019

Role of High-Dose Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction and Elevated Heart Rate.

Am J Med 2018 12 1;131(12):1473-1481. Epub 2018 Aug 1.

Veterans Affairs Medical Center, Washington, DC; George Washington University, Washington, DC. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjmed.2018.07.008DOI Listing
December 2018

Collagen biomarker bioprofiles predicting the antifibrotic response to eplerenone in myocardial infarction: findings from the REMINDER trial.

Clin Res Cardiol 2018 Dec 27;107(12):1192-1195. Epub 2018 Sep 27.

Université de Lorraine, Inserm, Centre d'Investigations Cliniques-Plurithématique 14-33, and Inserm U1116, CHRU de Nancy, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00392-018-1373-5
Publisher Site
http://dx.doi.org/10.1007/s00392-018-1373-5DOI Listing
December 2018

Future large-scale clinical trials in cardiovascular medicine: challenges and uncertainties.

Eur J Heart Fail 2018 12;20(12):1645-1648

University of Michigan School of Medicine, Ann Arbor, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ejhf.1360DOI Listing
December 2018

Individual participant data analysis of two trials on aldosterone blockade in myocardial infarction.

Heart 2018 11 25;104(22):1843-1849. Epub 2018 Apr 25.

Cardiology, Sorbonne Université-Paris 6, ACTION Study Group, Institut de Cardiologie (AP-HP), Centre Hospitalier Universitaire Pitié-Salpêtriėre, INSERM UMRS 1166, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/heartjnl-2018-312950DOI Listing
November 2018

Need to revisit heart failure treatment guidelines for hyperkalaemia management during the use of mineralocorticoid receptor antagonists.

Eur J Heart Fail 2018 09 8;20(9):1247-1251. Epub 2018 Jun 8.

Division of Cardiology, Department of Medicine, University of Michigan, Ann Arbor, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ejhf.1217DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6125193PMC
September 2018

Relation of Serum Potassium to Cardiovascular Events in Patients With Heart Failure and Preserved Ejection Fraction: "Mind the Gap".

Am J Hypertens 2018 09;31(10):1087-1089

Université de Lorraine, Inserm, Centre d'Investigations Cliniques- Plurithématique, Inserm U1116, CHRU Nancy, and F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ajh/hpy107DOI Listing
September 2018

Revisiting hyperkalaemia guidelines: rebuttal.

Eur J Heart Fail 2018 09;20(9):1255

Division of Cardiology, Department of Medicine, University of Michigan, Ann Arbor, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ejhf.1249DOI Listing
September 2018

Mineralocorticoid Receptor Antagonists in ST-Segment Elevation Myocardial Infarction.

JAMA Intern Med 2018 07;178(7):920-921

Centre d'Investigation Clinique 1433, Institut National de la Santé Et de la Recherche Médicale, Université de Lorraine and Centre Hospitalier Régional Universitaire, Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamainternmed.2018.1940DOI Listing
July 2018

Data-Driven Approach to Identify Subgroups of Heart Failure With Reduced Ejection Fraction Patients With Different Prognoses and Aldosterone Antagonist Response Patterns.

Circ Heart Fail 2018 07;11(7):e004926

Université de Lorraine INSERM, Centre, d'Investigations Cliniques Plurithématique 1433, INSERM U1116, CHRU de Nancy, F-CRIN INI-CRCT, France (J.P.F., K.D., P.R., F.Z.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCHEARTFAILURE.118.004926DOI Listing
July 2018

Effect of Patiromer on Hyperkalemia Recurrence in Older Chronic Kidney Disease Patients Taking RAAS Inhibitors.

Am J Med 2018 05 26;131(5):555-564.e3. Epub 2017 Nov 26.

Comprehensive Hypertension Center, Department of Medicine, University of Chicago Medicine, Ill.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00029343173120
Publisher Site
http://dx.doi.org/10.1016/j.amjmed.2017.11.011DOI Listing
May 2018

Is hyperkalaemia in heart failure a risk factor or a risk marker? Implications for renin-angiotensin-aldosterone system inhibitor use.

Eur J Heart Fail 2018 05 1;20(5):931-932. Epub 2018 Mar 1.

Department of Medicine, University of Michigan, Ann Arbor, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ejhf.1175DOI Listing
May 2018

The tolerability and safety profile of patiromer: a novel polymer-based potassium binder for the treatment of hyperkalemia.

Expert Opin Drug Saf 2018 May 22;17(5):525-535. Epub 2018 Apr 22.

b Medical affairs, Relypsa, Inc. , a Vifor Pharma Group Company , Redwood City , CA , USA.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14740338.2018.1
Publisher Site
http://dx.doi.org/10.1080/14740338.2018.1462335DOI Listing
May 2018

Spironolactone and Resistant Hypertension in Heart Failure With Preserved Ejection Fraction.

Am J Hypertens 2018 03;31(4):407-414

Division of Cardiovascular Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ajh/hpx210DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861580PMC
March 2018

Racial Differences in Characteristics and Outcomes of Patients With Heart Failure and Preserved Ejection Fraction in the Treatment of Preserved Cardiac Function Heart Failure Trial.

Circ Heart Fail 2018 03;11(3):e004457

From the Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (E.F.L., B.C., A.M.S., J.L., A.S.D., S.D.S., M.A.P.); Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL (S.J.S.); Veterans Affairs Medical Center Minneapolis, Minnesota (I.A.); University of Minnesota Medical School, Minneapolis (I.A.); Veterans Affairs Medical Center at San Diego, CA (I.A.); Montreal Heart Institute, Quebec, Canada (J.L.R., E.O.); Department of Medicine, Sarver Heart Center, University of Arizona, Tucson (N.K.S.); Division of Cardiology, University of Utah, Salt Lake City (J.C.F.); Department of Medicine, Howard University College of Medicine, Washington, DC (T.M.R.); Division of Cardiology, New York Methodist Hospital, Brooklyn (J.F.H.); Division of Cardiology, University of Illinois at Chicago (T.D.S.); National Heart, Lung, and Blood Institute, Bethesda, MD (R.B.); and University of Michigan School of Medicine, Ann Arbor (B.P.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCHEARTFAILURE.117.004457DOI Listing
March 2018

Stroke Risk in Patients With Reduced Ejection Fraction After Myocardial Infarction Without Atrial Fibrillation.

J Am Coll Cardiol 2018 02;71(7):727-735

National Institute of Health and Medical Research (INSERM), Center for Clinical Multidisciplinary Research 1433, INSERM U1116, University of Lorraine, Regional University Hospital of Nancy, French Clinical Research Infrastructure Network (F-CRIN) Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists, Nancy, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S07351097174192
Publisher Site
http://dx.doi.org/10.1016/j.jacc.2017.12.011DOI Listing
February 2018

Subcutaneous Furosemide in Heart Failure: Pharmacokinetic Characteristics of a Newly Buffered Solution.

JACC Basic Transl Sci 2018 Feb 7;3(1):25-34. Epub 2018 Feb 7.

Cardiology Division, University of Michigan School of Medicine, Ann Arbor, Michigan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacbts.2017.10.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059009PMC
February 2018

Mineralocorticoid receptor antagonists in patients with acute myocardial infarction - A systematic review and meta-analysis of randomized trials.

Am Heart J 2018 Jan 15;195:60-69. Epub 2017 Sep 15.

Population Health Research Institute, McMaster University, Hamilton Health Sciences, 237 Barton St E, Hamilton, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ahj.2017.09.010DOI Listing
January 2018

Teasing Apart Heart Failure With Preserved Ejection Fraction Phenotypes With Echocardiographic Imaging: Potential Approach to Research and Clinical Practice.

Circ Res 2018 01;122(1):23-25

From the Icahn School of Medicine at Mount Sinai, New York (E.A., J.N.); University of Minnesota School of Medicine, Minneapolis (Y.C.); Northwestern University Feinberg School of Medicine, Chicago, IL (S.J.S., R.O.B.); Department of Cardiology, CHRU-Nancy, France (O.H.); University of Michigan, Ann Arbor (B.P.); and Université de Lorraine, Nancy, France (F.Z.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCRESAHA.117.312180DOI Listing
January 2018

Mineralocorticoid Receptor Antagonists in High-Risk Heart Failure Patients With Diabetes Mellitus and/or Chronic Kidney Disease.

J Am Heart Assoc 2017 12 23;6(12). Epub 2017 Dec 23.

Inserm, Centre d'Investigations Cliniques-Plurithématique 14-33, Inserm U1116, CHRU Nancy Université de Lorraine, Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/JAHA.117.008054DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779066PMC
December 2017

Prognostic Importance of Temporal Changes in Resting Heart Rate in Heart Failure and Preserved Ejection Fraction: From the TOPCAT Study.

JACC Heart Fail 2017 11 11;5(11):782-791. Epub 2017 Oct 11.

Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchf.2017.08.018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592610PMC
November 2017

Sodium and Fluid Excretion With Torsemide in Healthy Subjects is Limited by the Short Duration of Diuretic Action.

J Am Heart Assoc 2017 Oct 5;6(10). Epub 2017 Oct 5.

Hypertension Research Center and Division of Nephrology and Hypertension, Georgetown University, Washington, DC

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/JAHA.117.006135DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721837PMC
October 2017

Serum potassium in patients with chronic heart failure: once we make a U-turn where should we go?

Eur Heart J 2017 10;38(38):2897-2899

Inserm, Centre d'Investigations Cliniques-Plurithématique 14-33, Inserm U1116, CHRU Nancy, Université de Lorraine, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehx537DOI Listing
October 2017

Association of digitalis treatment with outcomes following myocardial infarction in patients with heart failure or evidence of left ventricular dysfunction: an analysis from the High-Risk Myocardial Infarction Database Initiative.

Clin Res Cardiol 2017 Sep 28;106(9):722-733. Epub 2017 Apr 28.

INSERM, Centre d'Investigations Cliniques 9501, Université de Lorraine, CHU de Nancy, Institut Lorrain du Cœur et des Vaisseaux Louis Mathieu, 4 Rue du Morvan, 54500, Nancy, Vandoeuvre lès Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00392-017-1116-zDOI Listing
September 2017

Rationale for nebivolol/valsartan combination for hypertension: review of preclinical and clinical data.

J Hypertens 2017 09;35(9):1758-1767

aDepartment of Medicine, Tulane University, New Orleans, Louisiana, USA bDepartment of Cardiology, University of Cardiff, University Hospital, Wales Heart Research Institute, University Hospital of Wales, Cardiff, Wales, UK cSchool of Medicine, University of Michigan, Ann Arbor, Michigan dForest Research Institute, Inc, An Allergan affiliate, Jersey City, New Jersey, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000001412DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548499PMC
September 2017

Physical Activity and Prognosis in the TOPCAT Trial (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist).

Circulation 2017 Sep 21;136(11):982-992. Epub 2017 Jun 21.

From Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (S.M.H., B.C., A.M.S., E.F.L., M.A.P., S.D.S.); Department of Cardiology, VA Medical Center and Division of Cardiovascular Medicine, University of Minnesota, Minneapolis (I.A.); Cardiology Division, Northwestern University, Chicago, IL (S.J.S.); Division of Cardiology, University of Arizona, Tucson (N.K.S.); Division of Cardiovascular Medicine, University of Utah, Salt Lake City (J.D.F.); and Cardiovascular Medicine Division, University of Michigan School of Medicine, Ann Arbor (B.P.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.117.028002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592611PMC
September 2017

Tailoring mineralocorticoid receptor antagonist therapy in heart failure patients: are we moving towards a personalized approach?

Eur J Heart Fail 2017 08 12;19(8):974-986. Epub 2017 Apr 12.

Centre d'Investigation Clinique Plurithématique 1433, INSERM U1116, University of Lorraine, Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ejhf.814DOI Listing
August 2017

Declining Risk of Sudden Death in Heart Failure.

N Engl J Med 2017 07;377(1):41-51

From the British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences (L.S., P.S.J., M.C.P., J.J.V.M.), and Robertson Centre for Biostatistics and Clinical Trials, Institute of Health and Wellbeing (J.G.F.C.), University of Glasgow, the Department of Cardiology, Golden Jubilee National Hospital (M.C.P.), and the Cardiology Department, Glasgow Royal Infirmary (H.J.D.), Glasgow, and the National Heart and Lung Institute, Imperial College London, London (J.G.F.C.) - all in the United Kingdom; the Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston (B.L.C., S.D.S.); the Department of Cardiovascular Research, Istituto di Ricovero e Cura a Carattere Scientifico-Istituto di Ricerche Farmacologiche Mario Negri, Milan (S.B., R.L.), Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.), and Maria Cecilia Hospital, Gruppo Villa Maria Care and Research, Ettore Sansavini Health Science Foundation, Cotignola (L.T.) - all in Italy; Duke Clinical Research Institute, Duke University, Durham, NC (C.B.G.); Rikshospitalet University Hospital, Oslo (J.K.); the Department of Cardiology, Rigshospitalet Copenhagen University Hospital, Copenhagen (L.K.); Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas (M.P.); the Department of Medicine, University of Michigan, Ann Arbor (B.P.); the Center for Person-Centered Care (K.S.) and Sahlgrenska Academy (J.W.), University of Gothenburg, Gothenburg, Sweden; INSERM Centre d'Investigation Clinique 1433, Université de Lorraine and Centre Hospitalier Universitaire, Nancy, France (F.Z.); and the Medical University of South Carolina and Ralph H. Johnson Veterans Affairs Medical Center, Charleston (M.R.Z.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1609758
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1609758DOI Listing
July 2017

True rate of mineralocorticoid receptor antagonists-related hyperkalemia in placebo-controlled trials: A meta-analysis.

Am Heart J 2017 Jun 23;188:99-108. Epub 2017 Mar 23.

Universität des Saarlandes, Klinik für Innere Medizin III, Homburg/Saar, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ahj.2017.03.011DOI Listing
June 2017